Duchenne Muscular Dystrophy Market by Therapeutic Approach (Gene Therapy, Exon Skipping, etc.)
The Duchenne Muscular Dystrophy Treatment Market is influenced heavily by healthcare policies and economic factors. Due to the high cost of advanced therapies, government reimbursement programs play a critical role in market growth.
Countries with robust insurance coverage and rare disease policies see higher treatment adoption rates. Conversely, nations with limited healthcare funding struggle to provide access to expensive therapies. Pharmaceutical companies are increasingly partnering with governments to create payment models that spread costs over time, improving affordability.
This policy-driven approach is expected to be a key driver of market expansion in the next decade.
1 View